Evolent Health, Inc. Quarterly Costs and Expenses in USD from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Evolent Health, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2021 to Q2 2024.
  • Evolent Health, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $639M, a 30.3% increase year-over-year.
  • Evolent Health, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $2.4B, a 45.1% increase year-over-year.
  • Evolent Health, Inc. annual Costs and Expenses for 2023 was $2.04B, a 50.9% increase from 2022.
  • Evolent Health, Inc. annual Costs and Expenses for 2022 was $1.35B, a 41.9% increase from 2021.
  • Evolent Health, Inc. annual Costs and Expenses for 2021 was $950M, a 20% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.4B $639M +$149M +30.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $2.25B $653M +$215M +49.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $2.04B $577M +$193M +50.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $1.84B $529M +$189M +55.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.65B $491M +$166M +51.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $1.49B $438M +$138M +46.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $1.35B $384M Oct 1, 2022 Dec 31, 2022 10-K 2023-02-24
Q3 2022 $340M +$111M +48.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $325M +$94.8M +41.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $300M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 $229M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $230M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.